Latest Breakthrough medical device news

Featured News

Medical Devices and Biotechnology News

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

The marketing authorization is valid in all 27 European Union (“EU”) Member States, as well as Iceland, Liechtenstein and Norway. Pfizer and BioNTech have already initiated manufacturing of the monovalent XFG-adapted COVID-19 vaccine at risk to ensure supply readiness in anticipation of the respiratory disease season, when the demand for COVID-19 vaccination is expected to increase.

Clinical Trials | Funding | Mergers & Acquisitions | Market Reports

P&F Products & Features GmbH Announces Acquisition of AVVie GmbH

The acquisition strengthens P&F's structural heart portfolio with the addition of the AngelValve™ Augmentation System, a novel transcatheter solution for mitral regurgitation, further expanding the company's portfolio of next-generation transcatheter heart valve therapies and reinforcing its long-term commitment to structural heart innovation

Jascayd: EU approval marks new chapter in pulmonary fibrosis, says GlobalData

Jascayd is a first-in-class phosphodiesterase 4B (PDE4B) inhibitor that has been designed to have isoform selectivity to retain the antifibrotic and anti-inflammatory effects of PDE4 inhibition while avoiding the tolerability constraints that have limited previous nonselective PDE4 inhibitors in respiratory diseases

Executives On the Move

Industry Expert Bylines

Hospitals

Imaging

Association News

The Business of Healthcare

Careers

Nurses Corner

Health and Lifestyle

Articles of Interest